AssetMark’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
AssetMark's PPH Position: Q3 2026 in Review
AssetMark held its VanEck Pharmaceutical ETF (PPH) position steady in Q3 2026 at 15 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.
AssetMark first reported a position in PPH in Q3 2023 and has held it in 13 quarters since. The position peaked at $617K in Q3 2024. 124 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- AssetMark held 15 shares of VanEck Pharmaceutical ETF worth $1.64K as of Q3 2026.
- AssetMark left its VanEck Pharmaceutical ETF share count unchanged in Q3 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3106 holding.
- AssetMark first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and has held it in 13 quarters since.
- AssetMark's VanEck Pharmaceutical ETF position peaked at $617K in Q3 2024.
- 124 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.